Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SNK-02 by NKGen Biotech for Solid Tumor: Likelihood of Approval
SNK-02 is under clinical development by NKGen Biotech and currently in Phase I for Solid Tumor. According to GlobalData, Phase...